Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2026 Volume 32 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2026 Volume 32 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report Open Access

A thoracic SMARCA4‑deficient undifferentiated tumor: A case report

  • Authors:
    • Xiaocheng Wang
    • Miao Chen
    • Mingzhe Wang
    • Chengjun Ban
    • Lishan Zhang
    • Heng Zou
    • Hongwu Wang
    • Bing Yang
  • View Affiliations / Copyright

    Affiliations: First Clinical Medical School, Beijing University of Chinese Medicine, Beijing 100105, P.R. China, Department of Pulmonology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100007, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 533
    |
    Published online on: September 29, 2026
       https://doi.org/10.3892/ol.2026.15888
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Thoracic SWI/SNF‑related BAF chromatin remodeling complex subunit ATPase 4 (SMARCA4)‑deficient undifferentiated tumor (SMARCA4‑UT) is a newly recognized, high‑grade malignant neoplasm that is rare in clinical practice. There is no standardized or clearly defined treatment protocol for SMARCA4‑UT in clinical guidelines. The current study reports the case of a 54‑year‑old male patient who presented with a 2‑month history of an intermittent productive cough. Bronchoscopy demonstrated a neoplasm in the anterior segment of the right upper lobe bronchus, which almost obstructed the lumen, with a hypervascular surface, suggestive of a right upper lobe carcinoma. Histopathological examination confirmed a poorly differentiated carcinoma. Immunohistochemical analysis demonstrated a SMARCA4 gene mutation in exon 4, classifying the tumor as SMARCA4‑deficient undifferentiated lung carcinoma. The patient developed superior vena cava syndrome (SVCS), requiring emergent percutaneous stent placement. Treatment also included computed tomography‑guided cryoablation and radiofrequency ablation (RFA), alongside targeted molecular therapy with crizotinib. Despite aggressive multimodal therapy, the patient succumbed to tumor thrombosis at 1 month post‑treatment. Overall, SMARCA4‑UT is rare and diagnostically challenging, lacking standardized treatment guidelines. In clinical practice, cryoablation with argon‑helium and RFA may provide palliative benefits by alleviating tumor burden and improving quality of life. Endovascular intervention provides a rapid and effective approach to alleviate tumor‑induced SVCS. However, subsequent anticoagulation and antineoplastic therapies require further investigation to determine their efficacy in the management of such cases.
View Figures

Figure 1

Hematoxylin and eosin staining of the
carcinoma. Samples were stained and analyzed using the Diff-Quik
staining method. The staining solution contains the acidic dye
eosin and the basic dye methylene blue. The specific procedure was
as follows: Diff-Quik A solution, Diff-Quik B solution,
phosphate-buffered saline (PBS) and distilled water were
respectively placed in covered glass staining jars; slides were
sequentially immersed in Diff-Quik A solution (10–30 sec), rinsed
in PBS and drained, then immersed in Diff-Quik B solution (20–40
sec), and finally washed with distilled water, blotted with
absorbent paper and wiped to remove residual liquid from the edges
of the slides. Staining was performed at room temperature
(20–25°C), with a total staining time of 30–70 sec. Observation was
carried out under a light microscope at ×40 magnification.

Figure 2

Chest computed tomography performed at
Dongzhimen Hospital in April 2024. Occupation of the upper lobe of
the right lung with mediastinal lymph node metastasis, and invasion
of the main trunk of the right pulmonary artery; Multiple small
nodules in both lungs, leading to the consideration of possible
lung metastases; Chronic inflammation in the lower lobe of the
right lung; Right superior vena cava stenting; Small amount of
pericardial effusion and arteriosclerosis; Right pleural
effusion.

Figure 3

Chest computed tomography performed at
Dongzhimen Hospital in April 2024 (9 days after the previous scans
shown in Fig. 2). Occupation of the
upper lobe of the right lung with mediastinal lymph node
metastasis; Multiple small nodules in both lungs, leading to the
consideration of possible lung metastasis; Chronic inflammation in
the lower lobe of the right lung; Right superior vena cava
stenting; Small amount of pericardial effusion and
arteriosclerosis; Right pleural effusion.

Figure 4

Chest computed tomography performed at
Dongzhimen Hospital in May 2024. In comparison with the images
captured in April 2024, the current images revealed occupation of
the upper lobe of the right lung and metastasis of the mediastinal
lymph node, with no obvious changes from before; multiple small
nodules in both lungs, leading to the consideration of possible
lung metastases, with a slight increase in size than before;
chronic inflammation in the lower lobe of the right lung; right
superior vena cava stenting; a small amount of pericardial effusion
and arteriosclerosis; and right pleural effusion.

Figure 5

Enhanced neck and chest computed
tomography performed at Hulunbeir City People's Hospital in June
2024. In comparison with the images captured in May 2024, the
current images revealed occupation of the upper right hilar area,
with no significant interval change in size, leading to the
consideration of a malignant lesion with obstructive changes and
mediastinum invasion. Multiple nodules were present in both lungs,
roughly the same as before, and metastases were considered. The
mediastinum, bilateral subclavian and axillary lymph nodes were
enlarged with uneven density, and metastasis was considered. After
the superior vena cava stent, filling defect images were seen in
the lymph nodes, as well as a tumor thrombus.
View References

1 

Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S, et al: The 2021 WHO classification of lung tumors: Impact of advances since 2015. J Thorac Oncol. 17:362–387. 2022. View Article : Google Scholar : PubMed/NCBI

2 

Nambirajan A and Jain D: Recent updates in thoracic SMARCA4-deficient undifferentiated tumor. Semin Diagn Pathol. 38:83–89. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Jiang J, Chen Z, Gong J, Han N and Lu H: Thoracic SMARCA4-deficient undifferentiated tumor. Discov Oncol. 14:512023. View Article : Google Scholar : PubMed/NCBI

4 

Li X, Tian S, Shi H, Ta N, Ni X, Bai C, Zhu Z, Chen Y, Shi D, Huang H, et al: The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: Focusing immunotherapy, tumor microenvironment and epigenetic regulation. Cancer Gene Ther. 31:687–697. 2024. View Article : Google Scholar : PubMed/NCBI

5 

Longo V, Catino A, Montrone M, Montagna ES, Pesola F, Marech I, Pizzutilo P, Nardone A, Perrone A, Gesualdo M and Galetta D: Treatment of thoracic SMARCA4-deficient undifferentiated tumors: Where we are and where we will go. Int J Mol Sci. 25:32372024. View Article : Google Scholar : PubMed/NCBI

6 

Yang D and Wang Y: Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: A case report and literature review. Transl Lung Cancer Res. 13:443–452. 2024. View Article : Google Scholar : PubMed/NCBI

7 

Nagendrababu V, Chong BS, McCabe P, Shah PK, Priya E, Jayaraman J, Pulikkotil SJ and Dummer PMH: PRICE 2020 guidelines for reporting case reports in Endodontics: Explanation and elaboration. Int Endod J. 53:922–947. 2020. View Article : Google Scholar : PubMed/NCBI

8 

Patriarcheas V, Grammoustianou M, Ptohis N, Thanou I, Kostis M, Gkiozos I, Charpidou A, Trontzas I, Syrigos N, Kotteas E and Dimakakos E: Malignant superior vena cava syndrome: State of the art. Cureus. 14:e209242022.PubMed/NCBI

9 

Quencer KB: Superior vena cava syndrome: etiologies, manifestations, and treatments. Semin Intervent Radiol. 39:292–303. 2022. View Article : Google Scholar : PubMed/NCBI

10 

Sun L, Fu Q, Chen L, Di M and Cao J: SMARCA4-deficient non-small cell lung cancer with an EGFR mutation: A case report. Oncol Lett. 26:5132023. View Article : Google Scholar : PubMed/NCBI

11 

Lin Y, Yu B, Sun H, Zhang H, Hu Z, Zhang Y, Wu Z, Sun S, Zhao X, Yu H, et al: Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. J Cancer Res Clin Oncol. 149:8663–8671. 2023. View Article : Google Scholar : PubMed/NCBI

12 

Oncology Society of Chinese Medical Association and Chinese Medical Association Publishing House, . Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition). Zhonghua Zhong Liu Za Zhi. 45:539–574. 2023.(In Chinese). PubMed/NCBI

13 

Wang A, Jin Y, Cao Z, Lu L and Li Z: Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors. Cancer Med. 13:e68092024. View Article : Google Scholar : PubMed/NCBI

14 

Shi L, Lin L, Ding Y, Zeng Y and Chen X: Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure. Front Oncol. 12:10208752022. View Article : Google Scholar : PubMed/NCBI

15 

Yang P, Xiong F, Lin Y, Liang P and Tang C: Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: A case report. Transl Cancer Res. 12:1041–1048. 2023. View Article : Google Scholar : PubMed/NCBI

16 

Naito T, Umemura S, Nakamura H, Zenke Y, Udagawa H, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, et al: Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report. Thorac Cancer. 10:1285–1288. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Kunimasa K, Okami J, Takenaka S, Honma K, Kukita Y, Nagata S, Kawamura T, Inoue T, Tamiya M, Kuhara H, et al: Conversion surgery for advanced thoracic SMARCA4-deficient undifferentiated tumor with atezolizumab in combination with bevacizumab, paclitaxel, and carboplatin treatment: A case report. JTO Clin Res Rep. 2:1002352021.PubMed/NCBI

18 

Gantzer J, Davidson G, Vokshi B, Weingertner N, Bougoüin A, Moreira M, Lindner V, Lacroix G, Mascaux C, Chenard MP, et al: Immune-desert tumor microenvironment in thoracic SMARCA4-deficient undifferentiated tumors with limited efficacy of immune checkpoint inhibitors. Oncologist. 27:501–511. 2022. View Article : Google Scholar : PubMed/NCBI

19 

Ablation Expert Committee of the Chinese Society of Clinical Oncology and Expert Group on Tumor Ablation Therapy of the Chinese Medical Doctors Association; Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association; Tumor Ablation Committee of the Chinese College of Interventionalists, . Clinical practice guidelines:image-guided thermal ablation of primary and metastatic lung tumors (2021 edition). Zhonghua Nei Ke Za Zhi. 60:1088–1105. 2021.(In Chinese). PubMed/NCBI

20 

Tatli S, Tapan U, Morrison PR and Silverman SG: Radiofrequency ablation: Technique and clinical applications. Diagn Interv Radiol. 18:508–516. 2012.PubMed/NCBI

21 

Cariati M, Giordano G, Midulla M, Calati AM, Sacrini A, Raveglia F and Cornalba GP: Radiofrequency ablation of pulmonary lesions. Radiol Med. 112:149–156. 2007.(In English, Italian). View Article : Google Scholar : PubMed/NCBI

22 

Kwak KJ, Yu B, Lewandowski RJ and Kim DH: Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation. Theranostics. 12:2175–2204. 2022. View Article : Google Scholar : PubMed/NCBI

23 

Tatli S, Acar M, Tuncali K, Morrison PR and Silverman S: Percutaneous cryoablation techniques and clinical applications. Diagn Interv Radiol. 16:90–95. 2010.PubMed/NCBI

24 

Wright K, Digby GC, Gyawali B, Jad R, Menard A, Moraes FY and Wijeratne DT: Malignant superior vena cava syndrome: A scoping review. J Thorac Oncol. 18:1268–1276. 2023. View Article : Google Scholar : PubMed/NCBI

25 

Azizi AH, Shafi I, Zhao M, Chatterjee S, Roth SC, Singh M, Lakhter V and Bashir R: Endovascular therapy for superior vena cava syndrome: A systematic review and meta-analysis. EClinicalMedicine. 37:1009702021. View Article : Google Scholar : PubMed/NCBI

26 

Azizi AH, Shafi I, Shah N, Rosenfield K, Schainfeld R, Sista A and Bashir R: Superior vena cava syndrome. JACC Cardiovasc Interv. 13:2896–2910. 2020. View Article : Google Scholar : PubMed/NCBI

27 

Wong HCY, Chan AW, David E, Marta GN, Pan NY, Koller M, Lim F, Yeung R, Chow E and Simone CB II: Should endovascular stenting be used routinely as first-line treatment for malignant superior vena cava syndrome?-a critical review in the context of recent advances in oncological treatments. Ann Palliat Med. 12:803–815. 2023. View Article : Google Scholar : PubMed/NCBI

28 

Ratzon R, Tamir S, Friehmann T, Livneh N, Dudnik E, Rozental A, Hamburger-Avnery O, Pereg D, Derazne E, Brenner B, et al: Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome. J Thromb Thrombolysis. 47:121–128. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Gorospe L, Ajuria-Illarramendi O, Lage-Alfranca Y and Martín-Martín M: Differentiation of bland versus tumor thrombus in a lung cancer patient with an implanted central venous access device and a superior vena cava syndrome: 18F-FDG PET/CT findings. Jpn J Clin Oncol. 52:96–97. 2022. View Article : Google Scholar : PubMed/NCBI

30 

Tathireddy H, Rice D, Martens K, Shivakumar S and Shatzel J: Breaking down tumor thrombus: Current strategies for medical management. Thromb Res. 230:144–151. 2023. View Article : Google Scholar : PubMed/NCBI

31 

Serena G, Gonzalez J, Gaynor JJ, Salerno T, Verzaro R and Ciancio G: Pulmonary tumor embolization as early manifestation in patients with renal cell carcinoma and tumor thrombus: Perioperative management and outcomes. J Card Surg. 34:1018–1023. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Xu Y and Li M: Updated interpretation of Chinese Society of Clinical Oncology (CSCO) guidelines for the diagnosis and treatment of non-small cell lung cancer 2024. J Mod Med Health. 40:1801–1808. 2024.(In Chinese).

33 

Liang X, Zheng T, Ge Q and Huang R: Effective management of SMARCA4-deficient undifferentiated tumor by immunotherapy combined with chemotherapy and radiotherapy: Case report. Medicine (Baltimore). 104:e457472025. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang X, Chen M, Wang M, Ban C, Zhang L, Zou H, Wang H and Yang B: A thoracic SMARCA4‑deficient undifferentiated tumor: A case report. Oncol Lett 32: 533, 2026.
APA
Wang, X., Chen, M., Wang, M., Ban, C., Zhang, L., Zou, H. ... Yang, B. (2026). A thoracic SMARCA4‑deficient undifferentiated tumor: A case report. Oncology Letters, 32, 533. https://doi.org/10.3892/ol.2026.15888
MLA
Wang, X., Chen, M., Wang, M., Ban, C., Zhang, L., Zou, H., Wang, H., Yang, B."A thoracic SMARCA4‑deficient undifferentiated tumor: A case report". Oncology Letters 32.5 (2026): 533.
Chicago
Wang, X., Chen, M., Wang, M., Ban, C., Zhang, L., Zou, H., Wang, H., Yang, B."A thoracic SMARCA4‑deficient undifferentiated tumor: A case report". Oncology Letters 32, no. 5 (2026): 533. https://doi.org/10.3892/ol.2026.15888
Copy and paste a formatted citation
x
Spandidos Publications style
Wang X, Chen M, Wang M, Ban C, Zhang L, Zou H, Wang H and Yang B: A thoracic SMARCA4‑deficient undifferentiated tumor: A case report. Oncol Lett 32: 533, 2026.
APA
Wang, X., Chen, M., Wang, M., Ban, C., Zhang, L., Zou, H. ... Yang, B. (2026). A thoracic SMARCA4‑deficient undifferentiated tumor: A case report. Oncology Letters, 32, 533. https://doi.org/10.3892/ol.2026.15888
MLA
Wang, X., Chen, M., Wang, M., Ban, C., Zhang, L., Zou, H., Wang, H., Yang, B."A thoracic SMARCA4‑deficient undifferentiated tumor: A case report". Oncology Letters 32.5 (2026): 533.
Chicago
Wang, X., Chen, M., Wang, M., Ban, C., Zhang, L., Zou, H., Wang, H., Yang, B."A thoracic SMARCA4‑deficient undifferentiated tumor: A case report". Oncology Letters 32, no. 5 (2026): 533. https://doi.org/10.3892/ol.2026.15888
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team